Donato Bonifazi, CVBF’s CEO to Represent TEDDY, the European Network of Excellence for Paediatric Research, in the ACT EU Multi-Stakeholder Platform Annual Meeting
We are pleased to announce that our CEO, Donato Bonifazi, a permanent member of the Advisory Group of the ACT EU Multistakeholder [...]
Giovanni Migliaccio: Advancing Personalised Medicine for Rare Diseases
In the realm of rare disease research and education, collaboration and knowledge sharing are paramount. Giovanni Migliaccio, the CVBF’s Scientific Director and [...]
Our CEO to Present at Prestigious Global CardioVascular Clinical Trialists Workshop
We are proud to announce that Donato Bonifazi, CVBF’s CEO and Member of the Board of Directors of the Teddy European Network [...]
Innovative Therapies and Personalized Medicine for Rare Diseases: MOOC in Full Swing
As we are in full swing of the facilitation window in September, we're excited to share an update on the ongoing online [...]
RACE Act accelerates Paediatric Oncology Drug Testing, FDA reports
The U.S. Food and Drug Administration (FDA) has reported a significant increase in the number of planned studies to test drugs [...]
CVBF Attends EJP RD Final Conference in Bari
CVBF was among the participants at the European Joint Programme on Rare Diseases (EJP RD) Final Conference, held on 27-28 May 2024 [...]